Cost of Switching From An Originator Biologic (Remicade) To A Biosimilar
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1351
https://www.valueinhealthjournal.com/article/S1098-3015(16)32717-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1268
First Page :
A581
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32717-6&doi=10.1016/j.jval.2016.09.1351